Literature DB >> 81764

Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects.

G S Richardson, M A Carskadon, W Flagg, J Van den Hoed, W C Dement, M M Mitler.   

Abstract

Excessive daytime sleepiness is a complaint characterizing many disorders of the wakefulness--sleep cycle. This paper addresses the complaint of sleepiness objectively by an attempt to differentiate a group of control subjects from a group of patients with unambiguous narcolepsy. Fourteen control and 27 narcoleptic subjects were evaluated by one of three protocols involving nocturnal recordings, detailed interviews, and 5 or more 20-min opportunities to sleep offered at 2-h intervals beginning at 10.00 o'clock, +/- 30 min. Each 20-min opportunity to sleep was given to subjects lying in a darkened quiet room and asked to try to fall asleep. Polysomnographic variables were monitored and sleep was scored in 30-sec epochs by standard criteria. The interval from the start of each test to the first epoch of NREM (including stage 1 sleep) or REM sleep was called sleep latency. In two of the protocols, the subjects were awakened immediately after sleep onset. In the third protocol, the subjects were awakened after 10 min of sleep. Narcoleptics consistently fell asleep much more readily than did control subjects. We conclude that the Multiple Sleep latency test, in addition to providing opportunities to clinically document sleep onset REM sleep periods, can demonstrate pathological sleepiness. Based on these data, we suggest that an average sleep latency less than 5 min be set as the minimum cutoff point for pathological sleepiness.

Entities:  

Mesh:

Year:  1978        PMID: 81764      PMCID: PMC2391074          DOI: 10.1016/0013-4694(78)90162-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  4 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Quantification of sleepiness: a new approach.

Authors:  E Hoddes; V Zarcone; H Smythe; R Phillips; W C Dement
Journal:  Psychophysiology       Date:  1973-07       Impact factor: 4.016

3.  The pupillogram and narcolepsy. A method to measure decreased levels of wakefulness.

Authors:  R E Yoss; N J Moyer; K N Ogle
Journal:  Neurology       Date:  1969-10       Impact factor: 9.910

4.  235 cases of excessive daytime sleepiness. Diagnosis and tentative classification.

Authors:  C Guilleminault; W C Dement
Journal:  J Neurol Sci       Date:  1977 Jan-Feb       Impact factor: 3.181

  4 in total
  67 in total

1.  The assessment, diagnosis, and treatment of excessive sleepiness: practical considerations for the psychiatrist.

Authors:  Dewey McWhirter; Charles Bae; Kumaraswamy Budur
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Authors:  Christopher Drake; Timothy Roehrs; Naomi Breslau; Eric Johnson; Catherine Jefferson; Holly Scofield; Thomas Roth
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

3.  Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

Authors:  V Gentil; S Tavares; C Gorenstein; C Bello; L Mathias; G Gronich; J Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Daytime sleepiness is associated with decreased default mode network connectivity in both young and cognitively intact elderly subjects.

Authors:  Andrew M Ward; Donald G McLaren; Aaron P Schultz; Jasmeer Chhatwal; Brendon P Boot; Trey Hedden; Reisa A Sperling
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

Review 5.  Methods of testing for sleepiness [corrected].

Authors:  M M Mitler; J C Miller
Journal:  Behav Med       Date:  1996       Impact factor: 3.104

6.  Slow-wave activity surrounding stage N2 K-complexes and daytime function measured by psychomotor vigilance test in obstructive sleep apnea.

Authors:  Ankit Parekh; Anna E Mullins; Korey Kam; Andrew W Varga; David M Rapoport; Indu Ayappa
Journal:  Sleep       Date:  2019-03-01       Impact factor: 5.849

7.  Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects.

Authors:  T Duka; D Goerke; R Dorow; L Höller; K Fichte
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  Wrist actigraphy.

Authors:  Jennifer L Martin; Alex D Hakim
Journal:  Chest       Date:  2011-06       Impact factor: 9.410

Review 9.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

Review 10.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.